Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 3/20 | 0.41 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.36 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.36 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15797815 | 1.00 | DNM1 (0.50) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Fluoride SCHEMBL634433 | 0.97 | DNM1 (0.48) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL5874836 | 0.89 | DNM1 (0.60) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11828000 | 0.89 | DNM1 (0.57) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL15335412 | 0.89 | DNM1 (0.46) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL31621148 | 0.88 | DNM1 (0.43) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL115865 | 0.85 | DNM1 (0.55) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL3622952 | 0.85 | DNM1 (0.48) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL27421 | 0.85 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL28654242 | 0.85 | DNM1 (0.42) | DNM1TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230190664-A1 | CROSSLINKED PARTICLES | PENDANT BIOSCIENCES, INC. | 2023-06-22 | — | — | US | disclosed |
| US-20170100343-A1 | CROSSLINKED PARTICLES | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2017-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170100343-A1 | CROSSLINKED PARTICLES | EXOSC9, CD68, TNF | DNM1 2997/4885TSHR 3086/4885MEN1 1688/4885 |
| US-20230190664-A1 | CROSSLINKED PARTICLES | EXOSC9, CD68, TNF | DNM1 2997/4885TSHR 3086/4885MEN1 1688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.